Home LiteratureArticle Details
PMID: 24413734 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.

Nature genetics ·Vol. 46 ·No. 2 ·2014-02-00 ·Pages 166-70

Palomero T, Couronné L, Khiabanian H, Kim MY, Ambesi-Impiombato A, Perez-Garcia A, Carpenter Z, Abate F, Allegretta M, Haydu JE, Jiang X, Lossos IS, Nicolas C, Balbin M, Bastard C, Bhagat G, Piris MA, Campo E, Bernard OA, Rabadan R, Ferrando AA

Abstract

Peripheral T cell lymphomas (PTCLs) are a heterogeneous and poorly understood group of non-Hodgkin lymphomas. Here we combined whole-exome sequencing of 12 tumor-normal DNA pairs, RNA sequencing analysis and targeted deep sequencing to identify new genetic alterations in PTCL transformation. These analyses identified highly recurrent epigenetic factor mutations in TET2, DNMT3A and IDH2 as well as a new highly prevalent RHOA mutation encoding a p.Gly17Val alteration present in 22 of 35 (67%) angioimmunoblastic T cell lymphoma (AITL) samples and in 8 of 44 (18%) PTCL, not otherwise specified (PTCL-NOS) samples. Mechanistically, the RHOA Gly17Val protein interferes with RHOA signaling in biochemical and cellular assays, an effect potentially mediated by the sequestration of activated guanine-exchange factor (GEF) proteins. In addition, we describe new and recurrent, albeit less frequent, genetic defects including mutations in FYN, ATM, B2M and CD58 implicating SRC signaling, impaired DNA damage response and escape from immune surveillance mechanisms in the pathogenesis of PTCL.

MeSH Terms
Ataxia Telangiectasia Mutated Proteins/genetics Base Sequence CD58 Antigens/genetics Computational Biology DNA (Cytosine-5-)-Methyltransferases/genetics DNA Methyltransferase 3A DNA-Binding Proteins/genetics Dioxygenases Epigenesis, Genetic/genetics Escherichia coli Exome/genetics Fluorescent Antibody Technique HEK293 Cells High-Throughput Nucleotide Sequencing Humans Isocitrate Dehydrogenase/genetics Lymphoma, T-Cell, Peripheral/genetics Molecular Sequence Data Mutation, Missense/genetics Proto-Oncogene Proteins/genetics Proto-Oncogene Proteins c-fyn/genetics Sequence Analysis, RNA rhoA GTP-Binding Protein/genetics
Chemicals
CD58 Antigens DNA-Binding Proteins DNMT3A protein, human Proto-Oncogene Proteins RHOA protein, human IDH2, human Isocitrate Dehydrogenase Dioxygenases TET2 protein, human DNA (Cytosine-5-)-Methyltransferases DNA Methyltransferase 3A FYN protein, human Proto-Oncogene Proteins c-fyn ATM protein, human Ataxia Telangiectasia Mutated Proteins rhoA GTP-Binding Protein
Authors & Affiliations
21 authors, click to expand affiliations / ORCID
Palomero Teresa
1] Institute for Cancer Genetics, Columbia University, New York, New York, USA. [2] Department of Pathology, Columbia University Medical Center, New York, New York, USA. [3].
Couronné Lucile
1] Institute for Cancer Genetics, Columbia University, New York, New York, USA. [2].
Khiabanian Hossein
1] Department of Systems Biology, Columbia University, New York, New York, USA. [2].
Kim Mi-Yeon
Institute for Cancer Genetics, Columbia University, New York, New York, USA.
Ambesi-Impiombato Alberto
Institute for Cancer Genetics, Columbia University, New York, New York, USA.
Perez-Garcia Arianne
Institute for Cancer Genetics, Columbia University, New York, New York, USA.
Carpenter Zachary
Department of Systems Biology, Columbia University, New York, New York, USA.
Abate Francesco
1] Department of Systems Biology, Columbia University, New York, New York, USA. [2] Department of Control and Computer Engineering, Politecnico di Torino, Torino, Italy.
Allegretta Maddalena
Institute for Cancer Genetics, Columbia University, New York, New York, USA.
Haydu J Erika
Institute for Cancer Genetics, Columbia University, New York, New York, USA.
Jiang Xiaoyu
Division of Hematology-Oncology, Sylvester Comprehensive Cancer Center, Miami, Florida, USA.
Lossos Izidore S
1] Division of Hematology-Oncology, Sylvester Comprehensive Cancer Center, Miami, Florida, USA. [2] Department of Molecular and Cellular Pharmacology, University of Miami, Miami, Florida, USA.
Nicolas Concha
Hematology Service, Hospital Central de Asturias, Oviedo, Spain.
Balbin Milagros
Molecular Oncology Laboratory, Instituto Universitario de Oncología del Principado de Asturias, Hospital Universitario Central de Asturias, Oviedo, Spain.
Bastard Christian
INSERM U918, Rouen University, Centre Henri Becquerel, Rouen, France.
Bhagat Govind
Department of Pathology, Columbia University Medical Center, New York, New York, USA.
Piris Miguel A
1] Pathology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain. [2] Instituto de Formacion e Investigacion Marques de Valdecilla-IFIMAV, Santander, Spain.
Campo Elias ORCID
1] Hematopathology Section, Department of Pathology, Hospital Clinic, Barcelona, Spain. [2] Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.
Bernard Olivier A
1] INSERM U985, Villejuif, France. [2] Université Paris-Sud, Orsay, France. [3] Institut Gustave Roussy, Villejuif, France.
Rabadan Raul
1] Department of Systems Biology, Columbia University, New York, New York, USA. [2] Department of Biomedical Informatics, Columbia University, New York, New York, USA.
Ferrando Adolfo A
1] Institute for Cancer Genetics, Columbia University, New York, New York, USA. [2] Department of Pathology, Columbia University Medical Center, New York, New York, USA. [3] Department of Pediatrics, Columbia University Medical Center, New York, New York, USA.
References (35)
35 references, click to expand
  1. Rho family proteins modulate rapid apoptosis induced by cytotoxic T lymphocytes and Fas.
    J Biol Chem. 2000 Mar 31;275(13):9725-33 PMID: 10734125
  2. Rhotekin, a new putative target for Rho bearing homology to a serine/threonine kinase, PKN, and rhophilin in the rho-binding domain.
    J Biol Chem. 1996 Jun 7;271(23):13556-60 PMID: 8662891
  3. Chimeric transcript discovery by paired-end transcriptome sequencing.
    Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12353-8 PMID: 19592507
  4. Rho family GTPases.
    Biochem Soc Trans. 2012 Dec 1;40(6):1378-82 PMID: 23176484
  5. Fast and accurate long-read alignment with Burrows-Wheeler transform.
    Bioinformatics. 2010 Mar 1;26(5):589-95 PMID: 20080505
  6. I-TASSER: a unified platform for automated protein structure and function prediction.
    Nat Protoc. 2010 Apr;5(4):725-38 PMID: 20360767
  7. Rho GTPases in cancer cell biology.
    FEBS Lett. 2008 Jun 18;582(14):2093-101 PMID: 18460342
  8. Structure of a constitutively activated RhoA mutant (Q63L) at 1.55 A resolution.
    Acta Crystallogr D Biol Crystallogr. 2003 May;59(Pt 5):876-80 PMID: 12777804
  9. Ras and Rho GTPases: a family reunion.
    Cell. 2000 Oct 13;103(2):227-38 PMID: 11057896
  10. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.
    Blood. 2012 Feb 23;119(8):1901-3 PMID: 22215888
  11. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation.
    Oncogene. 2004 Oct 18;23(48):7990-8000 PMID: 15489916
  12. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
    Nucleic Acids Res. 1997 Sep 1;25(17):3389-402 PMID: 9254694
  13. Role of the Rho GTPase in bradykinin-stimulated nuclear factor-kappaB activation and IL-1beta gene expression in cultured human epithelial cells.
    J Immunol. 1998 Mar 15;160(6):3038-45 PMID: 9510209
  14. Coupling receptor tyrosine kinases to Rho GTPases--GEFs what's the link.
    Cell Signal. 2006 Nov;18(11):1834-43 PMID: 16725310
  15. deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data.
    PLoS Comput Biol. 2011 May;7(5):e1001138 PMID: 21625565
  16. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project.
    Ann Oncol. 2002 Jan;13(1):140-9 PMID: 11863096
  17. MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis.
    Mol Cell Biol. 1998 Apr;18(4):2416-29 PMID: 9528810
  18. The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management.
    Am J Hematol. 2012 May;87(5):511-9 PMID: 22508369
  19. UCSF Chimera--a visualization system for exploratory research and analysis.
    J Comput Chem. 2004 Oct;25(13):1605-12 PMID: 15264254
  20. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells.
    Nat Immunol. 2011 Jul 31;12(9):870-8 PMID: 21804557
  21. TET2 and DNMT3A mutations in human T-cell lymphoma.
    N Engl J Med. 2012 Jan 5;366(1):95-6 PMID: 22216861
  22. Thrombin and lysophosphatidic acid receptors utilize distinct rhoGEFs in prostate cancer cells.
    J Biol Chem. 2004 Jul 9;279(28):28831-4 PMID: 15143072
  23. Sirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction.
    J Clin Invest. 2011 Nov;121(11):4281-8 PMID: 21985785
  24. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
    Oncogene. 1999 Jul 15;18(28):4120-30 PMID: 10435593
  25. A mutant form of the rho protein can restore stress fibers and adhesion plaques in v-src transformed fibroblasts.
    Oncogene. 1999 Mar 25;18(12):2117-28 PMID: 10321736
  26. Analysis of activated GAPs and GEFs in cell lysates.
    Methods Enzymol. 2006;406:425-37 PMID: 16472675
  27. Adenylate cyclase toxin subverts phagocyte function by RhoA inhibition and unproductive ruffling.
    J Immunol. 2008 Oct 15;181(8):5587-97 PMID: 18832717
  28. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.
    Nature. 2012 Oct 4;490(7418):116-20 PMID: 22885699
  29. Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia.
    Cell Death Differ. 2010 Sep;17(9):1381-91 PMID: 20300113
  30. EGF-R signaling through Fyn kinase disrupts the function of integrin alpha6beta4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion.
    J Cell Biol. 2001 Oct 29;155(3):447-58 PMID: 11684709
  31. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1.
    J Biol Chem. 1995 Oct 13;270(41):23934-6 PMID: 7592586
  32. Dasatinib: a review of its use in the treatment of chronic myeloid leukaemia and Philadelphia chromosome-positive acute lymphoblastic leukaemia.
    Drugs. 2011 Sep 10;71(13):1771-95 PMID: 21902298
  33. Fast gapped-read alignment with Bowtie 2.
    Nat Methods. 2012 Mar 04;9(4):357-9 PMID: 22388286
  34. Signaling networks of Rho GTPases in cell motility.
    Cell Signal. 2013 Oct;25(10):1955-61 PMID: 23669310
  35. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.
    Cancer Cell. 2011 Jul 12;20(1):25-38 PMID: 21723201
Article Info
Journal
Nature genetics
Abbr.
Nat Genet
ISSN
1546-1718
Published
2014-02-00
Epub
2014-00-12
Pages
166-70
Language
English
Region
United States
NLM ID
9216904
PMCID
PMC3963408
Subset
IM
Grants
NCI NIH HHS · P30 CA013696 · United States
NCI NIH HHS · K12 CA090354-11 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]